Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes

Diabetes

Volumn 47, Issue 11, 1998, Pages 1809-1814

  Matsuda, Junichi ^a   Hosoda, Kiminori ^a,b   Itoh, Hiroshi ^a   Son, Cheol ^a   Doi, Kentaro ^a   Hanaoka, Ikuko ^a   Inoue, Gen ^a   Nishimura, Haruo ^a   Yoshimasa, Yasunao ^a   Yamori, Yukio ^b   Odaka, Hiroyuki ^c   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PIOGLITAZONE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; UNCOUPLING PROTEIN;

ADIPOSE TISSUE; ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENERGY EXPENDITURE; GENE EXPRESSION; GLUCOSE METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE; HYPOGLYCEMIC AGENTS; ION CHANNELS; MALE; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031693322     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.11.1809     Document Type: Article

References (37)

1. Nicholls DG, Locke RM: Thermogenic mechanisms in brown fat. Physiol Rev 64:1-64, 1984
2. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyruieis C, Bouilland F, Seldin MF, Surwit RS, Ricquier D, Warden CH: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269-272, 1997
3. Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ, Iris F, Ellis SJ, Woolf EA, Tartaglia LA: Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 46:900-906, 1997
4. Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP: Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408:39-42, 1997
5. Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Tanaka T, Fukunaga Y, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Nakao K: Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet. FEBS Lett 418:200-204, 1997
6. Vidal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB: UCP3: An uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 235:79-82, 1997
7. Boss O, Samec S, Kühne F, Bijlenga P, Assimacopoulos-Jeannet F, Seydoux J, Giacobino JP, Muzzin P: Uncoupling protein-3 expression in rodent skeletal muscle is modulated by food intake but not by changes in environmental temperature. J Biol Chem 273:5-8, 1998
8. Millet L, Vidai H, Andreelli F, Larrouy D, Riou JP, Ricquier D, Laville M, Langin D: Increased uncoupling protein-2 and -3 mRNA expression during fasting obese and lean human. J Clin Invest 100:2665-2670, 1997
9. Gong DW, He Y, Karas M, Reitman M: Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, β3-adrenergic agonists, and leptin. J Biol Chem 272:24129-24132, 1997
10. Larkin S, Mull E, Miao W, Pittner R, Albrandt K, Moore C, Young A, Denaro M, Beaumont K: Regulation of the third member of the uncoupling protein family, UCP3, by cold and thyroid hormone. Biochem Biophys Res Commun 240:222-227, 1997
11. Lanni A, De Felice M, Lombardi A, Moreno M, Fleury C, Ricquier D, Goglia F: Induction of UCP2 mRNA by thyroid hormones in rat heart. FEBS Lett 418:171-174, 1997
12. Masaki T, Yoshimatsu H, Kakuma T, Hidaka S, Kurokawa M, Sakata T: Enhanced expression of uncoupling protein 2 gene in rat white adipose tissue and skeletal muscle following chronic treatment with thyroid hormone. FEBS Lett 418:32:3-326, 1997
13. Bashan N, Burdett E, Gumà A, Sargeant R, Tumiati L, Liu Z, Klip A: Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol 264:C430-C440, 1993
14. Tsakiridis T, Vranic M, Klip A: Phosphatidylinositol 3-kinase and the actin network are not required for the stimulation of glucose transport caused by mitochondrial uncoupling: comparison with insulin action. Biochem J 309:1-5, 1995
15. Hofmann CA, Colca JR: New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care 15:1075-1078, 1992
16. Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T: Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Arzneim-Forsch/Drug Res 40 (I):263-267, 1990
17. Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S: Disposition of AD-4833(HCl), a new antidiabetic agent, in animals. Jpn Pharmacol Ther 24:2597-2617, 1996
18. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activator receptor gamma (PPAR gamma). J Biol Chem 270:12953-12956, 1995
19. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147-1156, 1994
20. Schoonjans K, Staels B, Auwerx J: Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925, 1996
21. Rothwell NJ, Stock MJ, Tedstone AE: Effects of ciglitazone on energy balance, thermogenesis and brown fat activity in the rat. Mol Cell Endocrinol 51:253-257, 1987
22. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839, 1998
23. Sugiyama Y, Shimura Y, Ikeda H: Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arzneim-Forsch/Drug Res 40 (I):436-440, 1990
24. Nishimura H, Zarnowski MJ, Sinipson IA: Glucose transporter recycling in rat adipose cells: effects of potassium depletion. J Biol Chem 268:19246-19253, 1993
25. Boss O, Samec S, Dulloo A, Seydoux J, Muzzin P, Giacobino JP: Tissue-dependent upregulation of rat uncoupling protein-2 expression in response to fasting or cold. FEBS Lett 412:111-114, 1997
26. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, Nakao K: Molecular cloning of rat leptin receptor isoform complementary DNAs: identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 225:75-83, 1996
27. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE: Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553-2561, 1996
28. Kozak UC, Kopecky J, Teisinger J, Enerbäck S, Boyer BB, Kozak LP: An upstream enhancer regulating brown-fat specific expression of the mitochondrial uncoupling protein gene. Mol Cell Biol 14:59-67, 1994
29. Suva JE, Rabelo R: Regulation of the uncoupling protein gene expression. Eur J Endocrinol 136:251-264, 1997
30. Foellmi-Adams LA, Wyse BM, Herron D, Nedergaard J, Kletzien RF: Induction of uncoupling protein in brown adipose tissue: synergy between norepinephrine and pioglitazone, and insulin-sensitizing agent. Biochem Pharmacol 52:693-701, 1996
31. Paulik MA, Lenhard JM: Thiazolidinediones inhibit alkaline phosphatase activity while increasing expression of uncoupling protein, deiodinase, and increasing mitochondrial mass in C3H10T1/2 cells. Cell Tissue Res 290:79-87, 1997
32. Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, Prins JB: Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes 47:138-141, 1998
33. Stevenson RW, Gibbs EW, Kreutter DK, McPherson RK, Clark DA, Hulin B, Goldstein SW, Parker JC, Swick AG, Treadway JL, Hargrove DM, Shulman GI: The thiazolidinedione drug series. In Diabetes Annual. 9th ed. Marshall SM, Home PD, Rizza RA, Eds. Amsterdam, Elsevier Science, 1995, p. 175-191
34. Tafuri SR: Troglitazone enhances differentiation, basal glucose uptake, and Glutl protein levels in 3T3-L1 adipocytes. Endocrinology 137:4706-4712, 1996
35. Stevenson RW, Kreutter DK, Andrews KM, Genereux PE, Gibbs EM: Possibility of distinct insulin-signaling pathways beyond phosphatidylinositol 3-kinase-mediating glucose transport and lipogenesis. Diabetes 47:179-185, 1998
36. Sandouk T, Reda D, Hoftmann C: Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 264:C1600-C1608, 1993
37. Sugiyama Y, Shimura Y, Ikeda H: Effect of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arzneim-Forsch/Drug Res 40 (I):436-440, 1990